Lupin gains on FDA approval

Lupin has added1% to Rs 576 on news that its subsidiary has received American health regulator’s approval to market its generic oral contraceptive tablets ‘Kurvelo’ in the US market. The company’s subsidiary — Lupin Pharmaceuticals Inc has received final …